Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Tosylate vs Propofol for Postoperative Sedation in Older Cardiac Surgery Patients
NCT07908121Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial of remimazolam in postoperative delirium (POD) (2 arms), sponsored by Nanjing First Hospital. Primary endpoint: Incidence of Postoperative Delirium at 7 days. Started Sep 2026; status: recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT07908121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07908121.